V015-2029 Screening compound: [(4-tert-butylphenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(pyrrolidine-1-carbonyl)-1,3-oxazol-2-yl]methyl}amine

V015-2029 Screening compound: [(4-tert-butylphenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(pyrrolidine-1-carbonyl)-1,3-oxazol-2-yl]methyl}amine
V015-2029 Screening compound: [(4-tert-butylphenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(pyrrolidine-1-carbonyl)-1,3-oxazol-2-yl]methyl}amine alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-2029
[(4-tert-butylphenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(pyrrolidine-1-carbonyl)-1,3-oxazol-2-yl]methyl}amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-2029

Molecular Formula

C30H36N4O2 (C30 H36 N4 O2)

Compound Name

[(4-tert-butylphenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(pyrrolidine-1-carbonyl)-1,3-oxazol-2-yl]methyl}amine

IUPAC name

[(4-tert-butylphenyl)methyl][2-(1H-indol-3-yl)ethyl]{[4-(pyrrolidine-1-carbonyl)-13-oxazol-2-yl]methyl}amine

SMILES

CC(C)(C)c1ccc(CN(CCc2c[nH]c3c2cccc3)Cc2nc(C(N3CCCC3)=O)co2)cc1

InChI

InChI=1S/C30H36N4O2/c1-30(2,3)24-12-10-22(11-13-24)19-33(17-14-23-18-31-26-9-5-4-8-25(23)26)20-28-32-27(21-36-28)29(35)34-15-6-7-16-34/h4-5,8-13,18,21,31H,6-7,14-17,19-20H2,1-3H3

InChI Key

WLQUUQVGHLQKPF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19829318

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

484.64

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.697

Distribution Coefficient, logD

5.697

Water Solubility, LogSw

-5.65

Polar Surface Area

48.948

Acid Dissociation Constant (pKa)

18.49

Base Dissociation Constant (pKb)

4.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

V015-2029 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Indole Derivatives (10091 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
Structure:
  • Cyclic compounds
  • Mimetics
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V015-2029 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-2029?
Check Price and Availability of V015-2029, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-2029 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-2029
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-2029
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-2029 available by request